Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 2 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
Page 1
Development of nomograms to predict recurrence after conversion hepatectomy for hepatocellular carcinoma previously treated with transarterial interventional therapy.
Eur J Med Res. 2023 Sep 9;28(1):328. doi: 10.1186/s40001-023-01310-4.
Eur J Med Res. 2023.
PMID: 37689775
Free PMC article.
Comparative efficacy of PD-1 inhibitors plus lenvatinib and regorafenib after lenvatinib failure for advanced hepatocellular carcinoma: a real-world study.
Guan R, Mei J, Li S, Lin W, Deng M, Wei W, Guo R.
Guan R, et al.
Hepatol Int. 2023 Jun;17(3):765-769. doi: 10.1007/s12072-022-10470-0. Epub 2023 Jan 7.
Hepatol Int. 2023.
PMID: 36609671
No abstract available.
Item in Clipboard
Four-gene signature predicting overall survival and immune infiltration in hepatocellular carcinoma by bioinformatics analysis with RT‒qPCR validation.
Guan R, Zou J, Mei J, Deng M, Guo R.
Guan R, et al.
BMC Cancer. 2022 Jul 30;22(1):830. doi: 10.1186/s12885-022-09934-1.
BMC Cancer. 2022.
PMID: 35907846
Free PMC article.
Item in Clipboard
The predictive value of vessels encapsulating tumor clusters in treatment optimization for recurrent early-stage hepatocellular carcinoma.
Chen ZY, Guo ZX, Lu LH, Mei J, Lin WP, Li SH, Wei W, Guo RP.
Chen ZY, et al.
Cancer Med. 2021 Aug;10(16):5466-5474. doi: 10.1002/cam4.4102. Epub 2021 Jul 1.
Cancer Med. 2021.
PMID: 34212527
Free PMC article.
Item in Clipboard
Immune-related adverse events predict responses to PD-1 blockade immunotherapy in hepatocellular carcinoma.
Lu L, Xing K, Wei W, Ling Y, Li P, Li S, Wang Y, Xie D, Guo R, Cai M.
Lu L, et al.
Int J Cancer. 2021 Apr 22. doi: 10.1002/ijc.33609. Online ahead of print.
Int J Cancer. 2021.
PMID: 33890283
Free article.
Item in Clipboard
Postoperative Adjuvant Transarterial Infusion Chemotherapy with FOLFOX Could Improve Outcomes of Hepatocellular Carcinoma Patients with Microvascular Invasion: A Preliminary Report of a Phase III, Randomized Controlled Clinical Trial.
Li S, Mei J, Wang Q, Guo Z, Lu L, Ling Y, Xu L, Chen M, Zheng L, Lin W, Zou J, Wen Y, Wei W, Guo R.
Li S, et al.
Ann Surg Oncol. 2020 Dec;27(13):5183-5190. doi: 10.1245/s10434-020-08601-8. Epub 2020 May 16.
Ann Surg Oncol. 2020.
PMID: 32418078
Clinical Trial.
Item in Clipboard
Cite
Cite